Albireo AB

Suède


 
Quantité totale PI 163
Rang # Quantité totale PI 7 895
Note d'activité PI 2,9/5.0    134
Rang # Activité PI 5 117
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

58 16
19 16
36 1
17
 
Dernier brevet 2024 - Asbt inhibitors in the treatment...
Premier brevet 2002 - Benzothiazepine and benzothiadia...
Dernière marque 2024 - PRUCISION
Première marque 2007 - ALBIREO

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Downloadable publications in the nature of questionnaires for use in the treatment of liver disea...
P/S Electronic questionnaires for use in the treatment of liver diseases and disorders and pediatric ...
2023 Invention Asbt inhibitors in the treatment of renal diseases. The invention relates to an apical sodium-de...
Invention Cocrystals of odevixibat. The present invention relates to a cocrystal of 1,1-dioxo-3,3-dibutyl-5...
Invention Asbt inhibitors in the treatment of renal diseases. The invention relates to an apical sodium-dep...
Invention Treating alagille syndrome (algs). Provided herein are methods for Alagille syndrome (ALGS) with...
Invention Treating alagille syndrome (algs). Provided herein are methods for Alagille syndrome (ALGS) with ...
Invention Pharmaceutical formulation of odevixibat. The invention relates to a pharmaceutical formulation,...
Invention Benzothia(di)azepine compounds and their use as bile acid modulators. The invention relates to 1,...
Invention Pharmaceutical combination comprising an ibat inhibitor and a bile acid binder. The present inve...
Invention Treating hepatitis. Provided herein are methods for treating hepatitis B and/or D with an Na+/tau...
Invention Treating hepatitis. Provided herein are methods for treating hepatitis B and/or D with an Na+/ta...
Invention Benzothia(di)azepine compounds and their use as bile acid modulators. The invention relates to 1...
Invention Subcutaneous administration of an asbt inhibitor. The invention relates to an apical sodium-depe...
Invention Subcutaneous administration of an asbt inhibitor. The invention relates to an apical sodium-depen...
Invention Benzothiadiazepine compounds and their use as bile acid modulators. The invention relates to 1,2...
Invention Treating progressive familial intrahepatic cholestasis (pfic) with ibat inhibitors. Provided her...
Invention Benzothia(di)azepine compounds and their use as bile acid modulators. The invention relates to ce...
2022 Invention Ibat inhibitors for the treatment of liver diseases. The present invention regards specific IBAT...
Invention Crystal modifications of odevixibat. The present invention relates to crystal modifications of 1,...
2021 Invention Treating progressive familial intrahepatic cholestasis (pfic) with ibat inhibitors. Provided here...
Invention Odevixibat for treating progressive familial intrahepatic cholestasis (pfic). Provided herein are...
Invention Benzothiazepine compounds and their use as bile acid modulators. The invention relates to 1,5-ben...
Invention Ibat inhibitors for the treatment of liver diseases. The present invention regards specific IBAT ...
2020 P/S Pharmaceutical products. Research and development in the field of orphan pediatric liver diseases...
Invention Benzothiadiazepine compounds and their use as bile acid modulators. The invention relates to 1,2,...
P/S Downloadable electronic publications in the nature of information brochures in the field of chole...
P/S Pharmaceutical product for the treatment of liver and gastrointestinal diseases and disorders
P/S Pharmaceutical product for the treatment of liver and gastrointestinal diseases and disorders
P/S Pharmaceutical product for the treatment of liver and gastrointestinal diseases and disorders
P/S Pharmaceutical product for the treatment of liver and gastrointestinal diseases and disorders.
P/S Pharmaceutical products for the treatment of liver and gastrointestinal diseases and disorders.
2019 P/S Downloadable electronic publications in the nature of information brochures in the field of pedia...
P/S Downloadable electronic publications in the nature of informational brochures in the field of ped...
Invention Pharmaceutical formulation of odevixibat. The invention relates to a pharmaceutical formulation, ...
2018 P/S Pharmaceutical products for the treatment of liver and gastrointestinal diseases and disorders. R...
P/S Pharmaceutical products for the treatment of liver and gastrointestinal diseases and disorders
P/S Pharmaceutical products.
P/S Pharmaceutical products for the treatment of liver and gastrointestinal diseases and disorders
P/S Research and development in the field of orphan pediatric liver diseases and other liver and gast...
2007 P/S Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic...